Why testing is important
Quantitative Covid-19 FluoBolt™-DUO-SN Antibody Test
Thank you for choosing the INOOlab antibody test.
The emergence of more and more infectious variants and the waning immunity after infection or vaccination create the constant need for SARS-CoV-2 antibody measurements.
Because the higher the level of certain antibodies, the higher the protection against infection.
In addition, there are large groups of people for whom the vaccination may not work well because their immune system is suppressed (e.g. cancer patients undergoing chemotherapy or people after an organ transplant who have to take immunosuppressants).
The question of whether and how many antibodies were formed after a natural infection also often remains unanswered. For this target group, the antibody status and its trend over time is relevant.
How does the INOOlab COVID-19 FluoBolt™- DUO SN antibody test work?
The highly sensitive and patented FluoBolt™ technology enables the simultaneous, i.e. dual, quantitative detection of antibodies against the spike protein (S1-RBD) and the nucleocapsid (NC) against SARS-CoV-2 and is therefore used to assess the immune status after infection and/or vaccination.
The test certificate will therefore tell you how well the vaccination has worked or whether you may have been infected without symptoms.
The blood sample is taken at the pharmacy by a small prick in the fingertip.
The collection of the blood drop is quick and uncomplicated.
You will receive the result within a few days.
You will receive a test certificate from a clinical laboratory sent directly to your e-mail box.
Collecting a blood sample is simple
What does the test certificate mean for me?
The presence of S1-RBD antibodies provides information whether and how well the vaccination has worked.
However, S1-RBD antibodies are also produced during an infection with the virus. Although no defined antibody threshold for safe protection against infection has been established until now, studies show that a high S1-RBD antibody level correlates with a low probability of infection.
The presence of nucleocapsid (NC) antibodies indicates whether you may have been infected with the virus without symptoms. Nucleocapsid antibodies do not protect against infection!
After an infection without symptoms, there is a certain increased probability that one belongs to a group of people who tend to have milder or no symptoms when infected with the currently known SARS-CoV-2 mutants.
If both S1-RBD antibodies and NC antibodies were detected, you most likely already had a COVID-19 infection.
If neither S1-RBD antibodies nor NC antibodies were detected, this indicates that you have neither undergone an infection nor that the necessary immune protection has been built up by a possible vaccination.
In the laboratory report that you will soon receive, your laboratory value will be interpreted by a specialist in laboratory medicine.